LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
Date
2020Journal
HaematologicaPublisher
Ferrata Storti FoundationType
Article
Metadata
Show full item recordSponsors
D.M. was supported by the Cooley’s Anemia Foundation, the French Foundation for Rare Diseases, the Région Midi-Pyrénées and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d’Avenir” ANINFIMIP (ANR-11EQPX-0003).Keyword
iron-refractory iron-deficiency anemiamatriptase-2
kinase inhibitor
LJ000328,
Serine Proteases
Hepcidins
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081633777&doi=10.3324%2fHAEMATOL.2019.236133&partnerID=40&md5=694f26f2b388f9a983b9b2fdfb7f2cd0; http://hdl.handle.net/10713/12375ae974a485f413a2113503eed53cd6c53
10.3324/HAEMATOL.2019.236133